Mama-Match
Peter MD review
PeterMD advertises tirzepatide at $149 initially, then $249/mo billed quarterly; the GLP-1/B12 package needs prescription and renewal clarification.
- Ask about HSA/FSA
- Independently scored
- Confirm total cost
Referral link, separate from the score
Our medical guides link to published research and official medication information. Provider reviews compare published costs and terms. These source checks do not replace clinical review or advice from your healthcare professional.
Peter MD at a glance
- Semaglutide
- Unconfirmed monthly quote
- Tirzepatide
- Unconfirmed monthly billing; $249/mo equivalent quarterly
- Coverage
- Tirzepatide excludes AL/ID; GLP-1/B12 also AK/HI
- Brand-name
- Compounded only
How we scored Peter MD
The Mama-Match Score of 43/100 for Peter MD combines six editorial assessments using the same weighted six-factor framework we apply to every provider. It is not a clinical quality rating. A recent source check does not mean every factor was rescored; read the published terms and the methodology alongside the number. Referral payments do not change the score.
Considers the intake steps, payment timing and information available before enrollment.
Considers the full treatment cost, introductory offers and billing commitments.
Considers the described clinical team, appointment access and ways to contact a prescriber.
Considers published state coverage and treatment-specific eligibility limits.
Considers follow-up appointments, refill reviews and access to ongoing clinical support.
Considers cancellation deadlines, refund limits and prepaid commitments.
How we verified this review
- Last reviewed
- October 2026
- Confidence
- Medium
- Primary sources
Company website
Tirzepatide starts at $149, then costs $249 per month as a quarterly payment. The GLP-1/B12 page lists a $315 package for 90 days; the individual ongoing total is unconfirmed.
Pricing
Prices re-verified
Compounded tirzepatide
$149
Plan
Initial offer
Initial offer; confirm supply and first charge.
Compounded tirzepatide
$249
Plan
Ongoing, billed quarterly
Monthly equivalent; $747 per quarter at this rate. Not independent monthly payment.
Ask your account administrator whether the exact charges qualify for HSA/FSA reimbursement and what itemized receipts you need. Prices reflect what Peter MD disclosed publicly at our last review and change often; confirm the current number on Peter MD's site.
What we like
- Published quarterly-equivalent tirzepatide rate
- Included consultation and shipping advertised
- Product-specific state exclusions
The caveats
- Tirzepatide monthly equivalent is billed quarterly
- GLP-1/B12 package mixes unrelated pricing content
- FDA wording does not establish approval of compounded products
- Limited refunds and short damaged-shipment notice window
Quarterly tirzepatide is not a monthly payment
PeterMD’s tirzepatide page advertises a $149 starting offer followed by $249 per month billed quarterly. At that stated ongoing rate, a quarter represents $747 before any individually disclosed differences. The initial offer is not the continuing price, and the continuing equivalent does not mean you can pay one month at a time. Ask what the first charge covers and when the full quarterly amount becomes due. This review keeps those conditional figures separate from a confirmed month-to-month total.
The GLP-1 page needs a clearer written quote
The separate GLP-1/B12 page publishes a three-month, ninety-day package marked $315 today. It also contains unrelated testosterone price-match language. That mixture makes a personal written quote particularly important: confirm which medicine, concentration and supply length the package actually covers, along with the renewal price. Dividing a package by three gives a comparison equivalent, not proof of a standard $105 monthly subscription. Do not add a product to a cart merely to resolve the site’s inconsistent presentation.
Compounding should not be presented as brand approval
The weight-loss pages describe pharmacy-compounded treatment while using FDA-approved language elsewhere and comparing their products with brand medicines. A compound is not an FDA-approved finished version of Wegovy or Zepbound. A shared ingredient does not establish equal clinical results or make the brands’ approval irrelevant. Ask for the actual medication label and pharmacy identity. This review does not repeat claims that brand pricing is only marketing or that the offered preparation has the same proven benefits as an approved product.
The broad clinic does not establish specialized maternal care
PeterMD offers weight management alongside testosterone, sexual-health, hair and longevity services, with a predominantly men-focused presentation. It also links women’s services, but that alone does not establish a postpartum or breastfeeding care pathway. Its weight-loss page advertises included physician consultation, optional laboratory testing and no separate membership fee. Confirm what follow-up is included for your prescription and who will answer medical questions. A large menu is useful only if the relevant care and costs are clear.
State limits vary by treatment
The tirzepatide page excludes Alabama and Idaho. The GLP-1/B12 page additionally excludes Alaska and Hawaii. Neither list should become a blanket description of every PeterMD service. Confirm the treatment at your address before planning around a quoted price. Delivery is described as included, but pharmacy processing and clinician approval still occur before transit. Ask which pharmacy will dispense the prescription and how to report a delayed or damaged shipment rather than relying on general nationwide language.
Cancel before the renewal processing date
The public policy requires an emailed cancellation at least forty-eight hours before an applicable automatic-renewal processing date. Received medication is nonreturnable and generally nonrefundable. Defective or damaged items have a replacement process requiring photographic evidence within twenty-four hours of receipt. That short window makes prompt inspection important. Stopping the next charge does not establish a refund of an earlier quarterly payment. Compare other provider reviews on commitment length, pharmacy transparency and cancellation before choosing an introductory price.
The bottom line
Best for: People who will obtain a written quote and can evaluate a quarterly commitment.
Other providers to compare
Providers to compare, with referral partners listed first. Placement and score are separate; some links earn MamaGLP a commission.
- Meet CoreAge Rx
Compounded semaglutide and tirzepatide with advertised flat prices; clarify the offer and renewal rules before paying.
- Meet yourEra
yourEra advertises semaglutide from $79 and tirzepatide from $159 with care and shipping included; confirm your refill amount and schedule.
- Meet Willow
Injections from $299 and $399/mo, with higher dose tiers; compounded tablets, named doctors and coverage in 36 states.
Keep comparing Peter MD
Head-to-heads and alternatives
Ranked boards
- Best GLP-1 for moms — a gentle first step
- Best GLP-1 for women — PCOS, cycles, perimenopause
- Best GLP-1 for first-timers (easiest to start)
- Most affordable GLP-1 with honest, clear pricing
- Best semaglutide for mothers — price and practicality
- Best semaglutide for women — compounded vs brand
- Best semaglutide for young moms — postpartum and budget
- Best tirzepatide for mothers — is it worth the extra
- Best tirzepatide for women — PCOS and insulin resistance
- Best GLP-1 with bilingual / Spanish-language support
Peter MD, answered
- Is tirzepatide $149 every month?
- No. The page advertises $149 initially then $249 monthly equivalent billed quarterly. At that rate it is $747 per quarter; confirm the first charge and conditions.
- When can I cancel?
- For applicable auto-renewals, policy requires email at least 48 hours before processing. Received prescription medicine is generally nonrefundable; damage evidence is required within 24 hours of receipt.
- Are the compounded products FDA-approved?
- No. Page language about ingredients or approved brands does not establish FDA approval of a finished compounded preparation.
Prices, states and verification reflect what Peter MD disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the published methodology. This is background information, not medical advice. Pregnancy and breastfeeding guidance depends on the drug and formulation. Read the current Wegovy label and Zepbound label. See our medical disclaimer and how we're funded.